EDIT vs AMZN: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AMZN has stronger fundamentals based on our AI analysis.

EDIT
Editas Medicine, Inc.
STRONG SELL
92%
Confidence
VS
AMZN
AMAZON COM INC
BUY
81%
Confidence

EDIT vs AMZN Fundamental Comparison

Metric EDIT AMZN
Revenue $40.5M $716.9B
Net Income $-160.1M $77.7B
Net Margin -395.0% 10.8%
ROE -586.6% 18.9%
ROA -85.8% 9.5%
Current Ratio 3.54x 1.05x
Debt/Equity 1.96x 0.17x
EPS $-1.80 $7.17

Green = Better metric | Red = Weaker metric

View Full EDIT Analysis →
View Full AMZN Analysis →

You Might Also Compare

EDIT vs AAPL AMZN vs MSFT EDIT vs GOOGL AMZN vs NVDA

EDIT vs AMZN: Frequently Asked Questions

Is EDIT or AMZN a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. EDIT is rated STRONG SELL (92% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.

How does EDIT compare to AMZN fundamentally?

Editas Medicine, Inc. has ROE of -586.6% vs AMAZON COM INC's 18.9%. Net margins are -395.0% vs 10.8% respectively.

Which stock pays higher dividends, EDIT or AMZN?

EDIT has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EDIT or AMZN for long term?

For long-term investing, consider that EDIT has STRONG SELL rating with 92% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EDIT vs AMZN?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EDIT vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.